Susquehanna International Group, LLP Mustang Bio, Inc. Call Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 11, 2021	SELL	$2.7 - $3.81 $116,370 - $164,211	-43,100 Reduced 76.01%	13,600 $45,000
Q1 2021 May 17, 2021	SELL	$3.02 - $5.16 $266,666 - $455,628	-88,300 Reduced 60.9%	56,700 $188,000
Q4 2020 Feb 16, 2021	BUY	$2.66 - $4.18 $345,534 - $542,982	129,900 Added 860.26%	145,000 $549,000
Q2 2020 Aug 14, 2020	SELL	$2.33 - $4.6 $126,752 - $250,239	-54,400 Reduced 78.27%	15,100 $48,000
Q4 2019 Feb 14, 2020	SELL	$2.57 - $4.08 $77,357 - $122,808	-30,100 Reduced 30.22%	69,500 $284,000
Q3 2019 Nov 14, 2019	BUY	$2.74 - $4.65 $98,914 - $167,865	36,100 Added 56.85%	99,600 $325,000
Q2 2019 Aug 14, 2019	BUY	$2.66 - $6.28 $168,910 - $398,780	63,500 New	63,500 $234,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.